These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3093069)

  • 1. Relationship between circulating plasminogen activators and tumor development in mice.
    Colombi M; Rebessi L; Boiocchi M; Barlati S
    Cancer Res; 1986 Nov; 46(11):5748-53. PubMed ID: 3093069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activators in nude mice xenotransplanted with human tumorigenic cells.
    Colombi M; Bellotti D; De Petro G; Barlati S
    Invasion Metastasis; 1995; 15(1-2):22-33. PubMed ID: 7672929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.
    de Vries TJ; Kitson JL; Silvers WK; Mintz B
    Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between urokinase-type plasminogen activator production and the metastatic ability of human rectal cancer cells.
    Marutsuka K; Suzumiya J; Kataoka H; Komada N; Koono M; Sumiyoshi A
    Invasion Metastasis; 1991; 11(4):181-91. PubMed ID: 1765431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
    Korner G; Bjornsson TD; Vlodavsky I
    J Cell Physiol; 1993 Mar; 154(3):456-65. PubMed ID: 8436596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase (u-PA) is produced by collecting duct principal cells and is post-transcriptionally regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor.
    Piedagnel R; Tiger Y; Lelongt B; Ronco PM
    J Cell Physiol; 2006 Feb; 206(2):394-401. PubMed ID: 16155905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
    Waghray A; Webber MM
    Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.
    Busso N; Belin D; Failly-Crépin C; Vassalli JD
    Cancer Res; 1987 Jan; 47(2):364-70. PubMed ID: 3098408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.
    De Petro G; Tavian D; Copeta A; Portolani N; Giulini SM; Barlati S
    Cancer Res; 1998 May; 58(10):2234-9. PubMed ID: 9605771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase.
    Schaefer U; Vorlova S; Machida T; Melchor JP; Strickland S; Levi R
    J Pharmacol Exp Ther; 2007 Jul; 322(1):265-73. PubMed ID: 17429057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hepatoma cell line plasminogen activator.
    Levin EG; Fair DS; Loskutoff DJ
    J Lab Clin Med; 1983 Oct; 102(4):500-8. PubMed ID: 6311924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis of human colon tumor cells in vivo: correlation with the overexpression of plasminogen activators and 72 kDa gelatinase.
    Shah V; Kumar S; Zirvi KA
    In Vivo; 1994; 8(3):321-6. PubMed ID: 7803712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.
    Sharma RK
    In Vivo; 1998; 12(2):209-17. PubMed ID: 9627804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin enhances release of tissue plasminogen activator from bovine corneal endothelial cells.
    Fukushima M; Nakashima Y; Sueishi K
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1576-83. PubMed ID: 2501229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.
    Mars WM; Kim TH; Stolz DB; Liu ML; Michalopoulos GK
    Cancer Res; 1996 Jun; 56(12):2837-43. PubMed ID: 8665523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
    Lijnen HR; Wagner EF; Collen D
    Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro.
    Paciucci R; Torà M; Díaz VM; Real FX
    Oncogene; 1998 Feb; 16(5):625-33. PubMed ID: 9482108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human primary colon carcinomas xenografted into nude mice. II. Modulation of tumor plasminogen activator activity by the host tissue environment.
    Cajot JF; Sordat B; Bachmann F
    J Natl Cancer Inst; 1986 Nov; 77(5):1099-107. PubMed ID: 3095580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator.
    Lijnen HR; Nelles L; Van Hoef B; De Cock F; Collen D
    Thromb Haemost; 1988 Oct; 60(2):247-50. PubMed ID: 3146141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.